CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. (CBIH) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $90.12 thousand for the 9-month period ending 2026-02-28, per its 10-Q filed 2026-04-16.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-04-16
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-02-28 was -$25.99K, a 274.71% decline year-over-year.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-11-30 was $115.16K, a 286.24% increase year-over-year.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-08-31 was $952.00.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-05-31 was -$50.42K.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$65.52K, a 177.27% decline from fiscal 2024.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $84.79K, a 96.78% increase from fiscal 2023.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $43.09K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-02-28 | -$25.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-16 | $89.17K derived: sum of 2 quarters · filed 2026-04-16 | $90.12K 10-Q · filed 2026-04-16 | $39.70K derived: sum of 4 quarters · filed 2026-04-16 | |
| 2025-11-30 | $115.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-19 | $116.12K 10-Q · filed 2026-02-19 | $65.69K derived: sum of 3 quarters · filed 2026-02-19 | $80.57K derived: sum of 4 quarters · filed 2026-04-16 | |
| 2025-08-31 | $952.00 10-Q · filed 2025-10-22 | -$49.47K derived: sum of 2 quarters · filed 2025-10-22 | -$34.59K derived: sum of 3 quarters · filed 2026-04-16 | -$4.78K derived: sum of 4 quarters · filed 2026-04-16 | |
| 2025-05-31 | -$50.42K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-22 | -$35.55K derived: sum of 2 quarters · filed 2026-04-16 | -$5.73K derived: sum of 3 quarters · filed 2026-04-16 | -$65.52K 10-K · filed 2025-09-22 | |
| 2025-02-28 | $14.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-16 | $44.70K derived: sum of 2 quarters · filed 2026-04-16 | -$15.09K 10-Q · filed 2026-04-16 | -$41.62K 10-Q/A · filed 2025-05-09 | -$76.53K derived: sum of 4 quarters · filed 2026-04-16 |
| 2024-11-30 | $29.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-19 | -$29.97K 10-Q · filed 2026-02-19 | -$91.41K derived: sum of 3 quarters · filed 2026-02-19 | -$47.40K derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-08-31 | -$59.79K 10-Q · filed 2025-10-22 | -$121.22K derived: sum of 2 quarters · filed 2025-10-22 | -$77.22K derived: sum of 3 quarters · filed 2025-10-22 | -$33.65K derived: sum of 4 quarters · filed 2025-10-22 | |
| 2024-05-31 | -$61.44K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-09-22 | -$17.43K derived: sum of 2 quarters · filed 2025-09-22 | $26.14K derived: sum of 3 quarters · filed 2025-09-22 | $84.79K 10-K · filed 2025-09-22 | |
| 2024-02-29 | $44.01K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2025-05-09 | $87.57K derived: sum of 2 quarters · filed 2025-05-09 | $146.23K 10-Q/A · filed 2025-05-09 | $170.65K derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-11-30 | $43.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-25 | $102.22K 10-Q · filed 2024-01-25 | $126.64K derived: sum of 3 quarters · filed 2024-10-21 | $149.66K derived: sum of 4 quarters · filed 2024-10-21 | |
| 2023-08-31 | $58.65K 10-Q · filed 2024-10-21 | $83.07K derived: sum of 2 quarters · filed 2024-10-21 | $106.10K derived: sum of 3 quarters · filed 2024-10-21 | ||
| 2023-05-31 | $24.42K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-16 | $47.44K derived: sum of 2 quarters · filed 2024-09-16 | $43.09K 10-K · filed 2024-09-16 | ||
| 2023-02-28 | $23.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-22 | $18.67K 10-Q · filed 2024-04-22 | |||
| 2022-11-30 | -$4.35K 10-Q · filed 2024-01-25 |